[ASAP] Engineered Recombinant EGFP-Azurin Theranostic Nanosystem for Targeted Therapy of Prostate Cancer 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00387 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
